Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · April 02, 2022

FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma

Journal of the National Cancer Institute

 

Additional Info

Journal of the National Cancer Institute
FOLFIRINOX as Initial Treatment for Localized Pancreatic Adenocarcinoma: A Retrospective Analysis by the Trans-Atlantic Pancreatic Surgery (TAPS) Consortium
J. Natl. Cancer Inst 2022 Feb 14;[EPub Ahead of Print], QP Janssen, JL van Dam, D Doppenberg, LR Prakash, CHJ van Eijck, WR Jarnagin, EM O' Reilly, A Paniccia, MG Besselink, MHG Katz, CD Tzeng, AC Wei, AH Zureikat, B Groot Koerkamp

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading